Bridge Biotherapeutics Inc.
Bridge Biotherapeutics Inc. is a virtually-operated, venture-backed clinical stage global biotech company.
Market cap
$117m
Enterprise value
$104m
Share price
KRW3520.00 288330.KQ
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | $183m | Post IPO Equity | |
| Total Funding | 000k | ||
LB Investment(exited)
K Partners(exited)
Uno Investment Corporation(exited)
Company K Partners(exited)
UTC Investment(exited)
SV Investment(exited)
JB Investment(exited)
| KRW | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | (89 %) | (70 %) | 57 % | (97 %) | (98 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 2 % | (303 %) | (1352 %) | (1403 %) | (38622 %) | (792625 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 2 % | (303 %) | (1366 %) | (1379 %) | (42321 %) | (907031 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | 195 % | 910 % | 1061 % | 25299 % | 405179 % |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.